ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Ophthalmology

Top Ophthalmology Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JACQUELINE GABAY MD

Ophthalmology

9,705

$1.27M

1165
1026 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

81%
prescriptions for brand name drugs

Avg: 68%

$131
Average prescription price

Avg: $97

DOUGLAS GRAYSON M.D.

Ophthalmology

6,968

$554K

1550
1437 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

79%
prescriptions for brand name drugs

Avg: 68%

$80
Average prescription price

Avg: $97

VIPUL LAKHANI MD

Ophthalmology

6,226

$604K

1115
1040 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 68%

$97
Average prescription price

Avg: $97

WARREN KLEIN M.D.

Ophthalmology

5,123

$421K

972
771 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

82%
prescriptions for brand name drugs

Avg: 68%

$82
Average prescription price

Avg: $97

JAI PAREKH M.D.

Ophthalmology

4,941

$1.04M

576
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

95%
prescriptions for brand name drugs

Avg: 68%

$210
Average prescription price

Avg: $97

HADLEY PHILLIPS DO

Ophthalmology

4,902

$440K

1176
1071 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

64%
prescriptions for brand name drugs

Avg: 68%

$90
Average prescription price

Avg: $97

MICHAEL MALEY MD

Ophthalmology

4,765

$443K

754
670 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 68%

$93
Average prescription price

Avg: $97

ARMAND FASANO M.D.

Ophthalmology

4,545

$505K

861
814 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

82%
prescriptions for brand name drugs

Avg: 68%

$111
Average prescription price

Avg: $97

PAUL LAMA M.D.

Ophthalmology

4,544

$397K

591
547 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 68%

$87
Average prescription price

Avg: $97

ELLIOT GRAND MD

Ophthalmology

4,349

$329K

725
698 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 68%

$76
Average prescription price

Avg: $97

DANIEL STEGMAN

Ophthalmology

4,017

$303K

815
681 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 68%

$76
Average prescription price

Avg: $97

ALEXANDER PALACIOS MD

Ophthalmology

3,899

$304K

611
565 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

70%
prescriptions for brand name drugs

Avg: 68%

$78
Average prescription price

Avg: $97

SAVEREN SCANNAPIEGO

Ophthalmology

3,726

$367K

692
554 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

77%
prescriptions for brand name drugs

Avg: 68%

$99
Average prescription price

Avg: $97

MARK FRIEDBERG M.D.

Ophthalmology

3,547

$304K

628
560 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

70%
prescriptions for brand name drugs

Avg: 68%

$86
Average prescription price

Avg: $97

SANDER COHEN M.D.

Ophthalmology

3,503

$248K

813
776 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

54%
prescriptions for brand name drugs

Avg: 68%

$71
Average prescription price

Avg: $97

DAVID INKELES MD

Ophthalmology

3,421

$312K

606
564 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 68%

$91
Average prescription price

Avg: $97

ANTHONY PANARIELLO M.D.

Ophthalmology

3,307

$314K

613
554 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

78%
prescriptions for brand name drugs

Avg: 68%

$95
Average prescription price

Avg: $97

ROBERT CHIANG M.D.

Ophthalmology

3,263

$368K

606
570 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

78%
prescriptions for brand name drugs

Avg: 68%

$113
Average prescription price

Avg: $97

HITESH PATEL M.D.

Ophthalmology

3,260

$341K

533
476 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 68%

$105
Average prescription price

Avg: $97

HOWARD FRIEDBERG M.D.

Ophthalmology

3,254

$326K

725
658 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

70%
prescriptions for brand name drugs

Avg: 68%

$100
Average prescription price

Avg: $97

DAVID NEWMAN

Ophthalmology

3,248

$250K

589
500 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 68%

$77
Average prescription price

Avg: $97

ALDEN LEIFER MD

Ophthalmology

3,202

$281K

526
461 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

73%
prescriptions for brand name drugs

Avg: 68%

$88
Average prescription price

Avg: $97

SHAWN KLEIN MD

Ophthalmology

3,144

$274K

597
482 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

85%
prescriptions for brand name drugs

Avg: 68%

$87
Average prescription price

Avg: $97

DAVID CHU MD

Ophthalmology

3,101

$269K

440
378 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 68%

$87
Average prescription price

Avg: $97

DAVID SMITH MD

Ophthalmology

3,062

$201K

687
664 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

54%
prescriptions for brand name drugs

Avg: 68%

$66
Average prescription price

Avg: $97

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank